NIH awards $6.9 million to prepare a potential Alzheimer’s treatment for future clinical trials

A multidisciplinary team of scientists led by Carlo Ballatore, Ph.D., at University of California San Diego and Kurt Brunden, Ph.D., at the University of Pennsylvania has been awarded a $6.9 million grant from the National Institute on Aging (NIA) to prepare a potential disease-modifying Alzheimer’s treatment for future clinical trials.

Preeclampsia Blood Marker? Pediatric Cardiac Doc Arrested; Afib-Detecting Ring

Expectant mothers might one day be able to take a blood test to predict their risk of preeclampsia late into pregnancy. (Scientific Reports) A higher

July 24, 2024

Keeler: Deion Sanders, CU Buffs, not ready for prime time, get punched in mouth by Nebraska – The Cannabist

LINCOLN, Neb. — You don’t bring a 30-carat diamond watch to a sword fight. A Maybach can’t block. An NIL deal won’t chip an angry

September 8, 2024

Heidelberg Pharma announces receipt of non-refundable upfront cash payment following the successful closing of its royalty purchase agreement with HealthCare Royalty – Biotech Investments

EQS-News: Heidelberg Pharma AG / Key word(s): Financing Heidelberg Pharma announces receipt of non-refundable upfront cash payment following the successful closing of its royalty purchase

March 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.